Effects of peripheral κ opioid receptor activation on inflammatory mechanical hyperalgesia in male and female rats
- PMID: 22819973
- PMCID: PMC3427391
- DOI: 10.1016/j.neulet.2012.07.018
Effects of peripheral κ opioid receptor activation on inflammatory mechanical hyperalgesia in male and female rats
Abstract
Activation of peripheral κ opioid receptors (KOR) effectively relieves pain and hyperalgesia in preclinical and clinical models of pain. Although centrally located KOR activation results in sexually dimorphic effects, it is unclear whether peripheral KOR also produces sex dependent effects in persistent inflammatory pain conditions. In this study, we investigated whether local administration of a specific KOR agonist, U50, 488 relieve mechanical hyperalgesia induced by the injection of complete Freund's adjuvant (CFA) in the rat hindpaw, and whether there are sex differences. The effects of U50, 488 were assessed three days after the induction of CFA-induced inflammation, a time point at which mechanical hyperalgesia was most prominent. There were no sex differences in baseline and CFA-induced changes in mechanical thresholds between male and female rats. Local treatment of U50, 488 produced moderate, but significant, anti-hyperalgesia in both male and female rats. However, U50, 488 was significantly more effective in male rats at the highest dose of U50, 488. We confirmed that the highest dose of U50, 488 used in this study did not produce systemic effects, and that the drug effect is receptor specific. On the basis of these results, we suggest that local KOR agonists are effective in mitigating mechanical hyperalgesia under a persistent inflammatory pain condition and that sex differences in anti-hyperalgesic effects become more evident at high doses.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
There are no conflicts of interest associated with the present study.
Figures
References
-
- Amarante LH, Alves DP, Duarte ID. Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine. Eur J Pharmacol. 2004 Jun 28;494(2–3):155–160. - PubMed
-
- Arendt-Nielsen L, Olesen AE, Staahl C, Menzaghi F, Kell S, Wong GY, Drewes AM. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain. Anesthesiology. 2009 Sep;111(3):616–624. - PubMed
-
- Bastos JV, Queiroz-Junior CM, Caliari MV, Francischi JN, Pacheco CM, Maltos KL. Peripheral kappa opioid receptors activation reduces alveolar bone loss in rats by modulating interleukin-6 and-10. Arch Oral Biol. 2011 Jun;56(6):540–548. - PubMed
-
- Bileviciute-Ljungar I, Spetea M. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats. Eur J Pharmacol. 2004 Jun 28;494(2–3):139–146. - PubMed
-
- Binder W, Carmody J, Walker J. Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids. J Pharmacol Exp Ther. 2000 Jan;292(1):303–309. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
